RAPID ACCESS TO INTERVENTION DEVELOPMENT (RAID) - ADDENDUM Release Date: December 13, 1999 NOTICE: CA-00-004 National Cancer Institute In the May 11,1998 issue of the NIH Guide for Grants and Contracts, the National Cancer Institute (NCI) announced a new initiative: Rapid Access to Intervention Development (RAID). The original Notice can be accessed at the following location: http://grants.nih.gov/grants/guide/notice-files/not98-070.html. The purpose of the present Notice is to announce a change to the program, effective immediately: requests for support should provide evidence of feasibility for the preparation of any product proposed for clinical trial. For more information concerning this new requirement, guidelines for submitting requests for support, and information on previously supported requests, visit the web site, http://dtp.nci.nih.gov/. RAID will make available to academic investigators, on a competitive basis, the preclinical development contract resources of NCI=s Developmental Therapeutics Program. RAID is not a grant program to originating investigators. The goal of RAID is the rapid movement of novel molecules and concepts from the laboratory to the clinic for proof-of-principle clinical trials. RAID will assist investigators who submit successful applications by providing any (or all) of the preclinical development steps that may be obstacles to clinical translation. These may include, for example, production, manufacture of products using current Good Manufacturing Practices (cGMP), formulation, and toxicology. Suitable agents for RAID include small molecules, biologics, or vaccines. This is the third Notice in the NIH Guide for Grants and Contracts regarding changes to the RAID program since its inception. A Notice released on June 16, 1999 clarified that 1) requests to produce materials ready for use in clinical trials must have a letter of commitment from an Institution willing to conduct the trial; and, 2) if the receipt dates, February 1 and August 1 of each year, fall on a weekend or holiday, the receipt date will be the following business day. A Notice released on December 18,1998 clarified that 1) academic investigators may have collaborations with small business partners and still qualify for RAID funding; and, 2) a maximum of two requests per investigator can be submitted per receipt date. http://grants.nih.gov/grants/guide/notice-files/not99-110.html. Requests for RAID resources are to be submitted as described in the web site. Written requests will be evaluated by a specially constituted RAID panel consisting of selected NCI staff (non voting) and outside experts from academia and industry. All requests for support must be submitted directly to the office listed below under INQUIRIES. INQUIRIES Inquiries are encouraged, and the opportunity to clarify issues or questions is welcome. Inquiries may be directed to: James C. Drake Coordinator, RAID Program Special Assistant to the Associate Director Developmental Therapeutics Program Division of Cancer Treatment and Diagnosis National Cancer Institute 6130 Executive Blvd., Room 843 Bethesda, MD 20892 Rockville, MD 20852 (for express/courier service) Telephone: (301) 496-8720 FAX: (301) 402-0831 Email: drakej@dtpax2.ncifcrf.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files. |